Chikungunya vaccine tested in Dominican Republic
The Huberto Bogaert Diaz dermatological institute’s Vaccination and Research Unit is taking part in a regional research project aimed at finding a vaccine for the chikungunya virus. A total of 78 volunteers are taking part in the clinical trial. The study is also underway in Puerto Rico, Haiti, Guadeloupe and Martinique, which are also affected by the disease.
The vaccine is being developed at the United States National Institutes of Health’s Vaccine Research Center (VCR).Dr. Yeycy Donastorg Cabral, lead researcher for the Huberto Bogaert Institute said that a first phase of the vaccination trial was a test in the United States with 25 volunteers. She now hopes to test the vaccine on 106 volunteers, 78 of whom are already on board. The volunteers will receive either an injection of the vaccine or a placebo before being monitored for 18 months to evaluate the experimental vaccine’s safety and capacity to generate an immune system response in participants. Volunteers need to be between the ages of 18 to 60, and must commit to 11 follow-up visits and have no plans to leave the country in the next 18 months.
Source: DR1, Elcaribe
Aug 9, 2016
Category: DR News |